UC39: Sepsis Early Warning Agent

The Problem

Sepsis kills approximately 270,000 Americans annually. Every hour of delayed treatment increases mortality by 7.6%; the golden window for effective intervention is 3 hours. Current sepsis detection relies on manual vital sign monitoring and clinician pattern recognition, which is error-prone during high-acuity situations. Validated scoring systems (qSOFA, SOFA) exist but are inconsistently applied in real-time.

What the Agent Does

Continuously monitors real-time vital signs streamed from bedside monitors (temperature, heart rate, blood pressure, respiratory rate, oxygen saturation)
Retrieves lab results as they result (WBC count, lactate, creatinine, bilirubin) and integrates into dynamic risk calculation
Calculates validated sepsis scores (qSOFA, SOFA) with real-time updates every 5 minutes
Identifies early indicator patterns: rapid temperature rise, HR >90 + RR >20, lactate >2 mmol/L
Escalates alerts to nursing station and ICU team when threshold is crossed; displays alert with recommended actions (blood cultures, empiric antibiotics per protocol)
Logs all alert decisions for auditing and clinical review

Data Requirements

Primary Data Sources: Real-time vital sign streams (bedside monitors: Philips, GE), lab results (acute lab analyzer interface), medication administration records (antibiotics given), patient demographics (age, chronic conditions)
Classification: PHI/PII (patient identifiers, continuous vital data)
Quality Metrics: Vital sign transmission latency <2 seconds; alert sensitivity >90% (catch true sepsis cases); specificity >80% (minimize false alarms)
Complexity: Very High (real-time streaming data, validated clinical algorithms, integration with multiple hardware systems)
Systems: Epic EHR, Cerner, Philips IntelliVue platform, GE CareVue

Score Breakdown

Criterion	Weight	Score (1-5)	Weighted
Time Recaptured	15%	4	0.60
Error Reduction	10%	4	0.40
Cost Avoidance	10%	4	0.40
Strategic Leverage	5%	4	0.20
Data Availability	15%	4	0.60
Process Clarity	15%	4	0.60
Ease of Implementation	10%	4	0.40
Fallback Available	10%	4	0.40
Audience (Int/Ext)	10%	4	0.40
Composite	100%		3.85

Why It Scores Well

Life-Saving Impact: Early sepsis recognition directly reduces mortality and organ failure rates
Evidence Base: Sepsis bundles and early detection validated in Surviving Sepsis Campaign guidelines
Regulatory Fit: CMS incentivizes sepsis detection through SEP-1 quality measure; agencies actively promote AI in sepsis
Real-World Deployment: Multiple FDA-cleared sepsis prediction tools in market (Sepsis Watch, TempWatch)
Operational Benefit: Reduces alarm fatigue by integrating multiple signals into single, high-confidence alert

Regulatory Alignment

FDA: Sepsis prediction tools may require 510(k) premarket approval depending on autonomy level and intended use. Tools that recommend specific treatment decisions typically require review; advisory-only tools have lower bar.
CMS SEP-1 Quality Measure: Sepsis identification and early treatment protocols are publicly reported quality metrics
Joint Commission NPSG: Sepsis safety initiatives are accredited standard
State Medical Board: Ensure alerts do not constitute independent medical diagnosis (must be advisory to clinical team)

Sprint Factory Fit

4 to 5 sprints (bedside monitor API integration, lab data pipeline, algorithm development/validation, FDA premarket pathway, clinical governance review)

Sprints Required: 4 to 5 sprints (bedside monitor API integration, lab data pipeline, algorithm development/validation, FDA premarket pathway, clinical governance review)
Timeline: 10 to 12 weeks from requirements to pilot; 6 to 8 months for FDA clearance if required
Governance: Require ICU medical director approval; clinical validation against gold-standard sepsis diagnosis in first 100 cases; audit false alarm rate weekly
Success Metrics: Alert sensitivity >90%; specificity >75%; clinician satisfaction >4.1/5; time-to-antibiotic administration reduced by 20 minutes

Comparable Implementations

Deploy This Use Case with the Sprint Factory

From zero to a governed, production agent in 6 weeks.

Sprint Factory Schedule a Briefing

Related Use Cases

Real-Time Clinical

Radiology Preliminary "Second Look"

Score: 3.7/5.0

Real-Time Clinical

Wound Care Progress Monitor

Score: 3.55/5.0

Real-Time Clinical

Behavioral Health Crisis Detection

Score: 3.45/5.0

Governance Risks to Consider

Before deploying this use case, review these agentic AI risks from the Corvair Risk Catalogue. Each is scored on the DAMAGE framework and mapped to regulatory expectations.